Engineered liposomes mediated approach for targeted colorectal cancer drug Delivery: A review
Colorectal cancer (CRC) continues to be one of the most prevalent and deadliest forms of cancer worldwide, despite notable advancements in its management. The prognosis for metastatic CRC remains discouraging, with a relative 5-year survival rate for stage IV CRC patients. Conventional treatments fo...
| 发表在: | International Journal of Pharmaceutics |
|---|---|
| 主要作者: | |
| 格式: | Review |
| 语言: | English |
| 出版: |
Elsevier B.V.
2024
|
| 在线阅读: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85181882337&doi=10.1016%2fj.ijpharm.2023.123735&partnerID=40&md5=a6c0fe8ff883fc14b62d5c95d8a58466 |